HomeIKT • NASDAQ
add
Inhibikase Therapeutics Inc
Previous close
$1.68
Day range
$1.70 - $1.83
Year range
$1.33 - $2.37
Market cap
238.98M USD
Avg Volume
3.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.17M | 27.12% |
Net income | -12.73M | -4.96% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.73M | 55.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 178.76M | 83.27% |
Total assets | 181.20M | 83.78% |
Total liabilities | 8.30M | 122.33% |
Total equity | 172.90M | — |
Shares outstanding | 127.88M | — |
Price to book | 1.65 | — |
Return on assets | -10.99% | — |
Return on capital | -11.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -12.73M | -4.96% |
Cash from operations | -7.52M | -40.60% |
Cash from investing | -98.85K | 99.74% |
Cash from financing | 108.57M | 8.91% |
Net change in cash | 100.95M | 81.64% |
Free cash flow | 2.42M | 302.97% |
About
Founded
2008
Headquarters
Website
Employees
35
